204 related articles for article (PubMed ID: 15913472)
1. Trials of gene therapy for pancreatic carcinoma.
Halloran CM; Ghaneh P; Costello E; Neoptolemos JP
Curr Gastroenterol Rep; 2005 Jun; 7(3):165-9. PubMed ID: 15913472
[No Abstract] [Full Text] [Related]
2. Gene therapy and pancreatic cancer.
Pearson AS; Bouvet M; Evans DB; Roth JA
Front Biosci; 1998 Nov; 3():E230-7. PubMed ID: 9792901
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathobiology of pancreatic adenocarcinoma.
Mangray S; King TC
Front Biosci; 1998 Nov; 3():D1148-60. PubMed ID: 9820739
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
Talar-Wojnarowska R; Malecka-Panas E
Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapies for killing tumor cells.
Gazdar AF; Minna JD
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10028-30. PubMed ID: 11526225
[No Abstract] [Full Text] [Related]
6. A case of pancreatic adenocarcinoma with novel K-ras mutation and long term survival.
Toyooka S; Tsukuda K; Mizuta M; Soh J; Shirakawa K; Shimizu K; Shimizu N
Am J Gastroenterol; 2002 Jul; 97(7):1852-3. PubMed ID: 12135058
[No Abstract] [Full Text] [Related]
7. A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma.
Jaffee EM; Abrams R; Cameron J; Donehower R; Duerr M; Gossett J; Greten TF; Grochow L; Hruban R; Kern S; Lillemoe KD; O'Reilly S; Pardoll D; Pitt HA; Sauter P; Weber C; Yeo C
Hum Gene Ther; 1998 Sep; 9(13):1951-71. PubMed ID: 9741433
[No Abstract] [Full Text] [Related]
8. Tumor-suppressor genes in pancreatic cancer.
Hruban RH; Offerhaus GJ; Kern SE; Goggins M; Wilentz RE; Yeo CJ
J Hepatobiliary Pancreat Surg; 1998; 5(4):383-91. PubMed ID: 9931387
[No Abstract] [Full Text] [Related]
9. Re: Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
Malats N; Porta M; Fernandez E; Real FX
J Natl Cancer Inst; 1994 Sep; 86(17):1353-4; author reply 1355. PubMed ID: 7914938
[No Abstract] [Full Text] [Related]
10. Quantitative analysis of ras gene mutation in pancreatic juice for diagnosis of pancreatic adenocarcinoma.
Tada M; Teratani T; Komatsu Y; Kawabe T; Shiratori Y; Omata M
Dig Dis Sci; 1998 Jan; 43(1):15-20. PubMed ID: 9508517
[TBL] [Abstract][Full Text] [Related]
11. Detection of multiple hepatic micrometastases in pancreatic adenocarcinoma with a solitary liver metastasis by direct sequencing of the K-ras gene: a case report.
Suwa H; Hosotani R; Okino T; Monden K; Arii S; Inoue K; Kogire M; Ohshio G; Fukumoto M; Imamura M
Surgery; 1999 Jan; 125(1):113-6. PubMed ID: 9889807
[No Abstract] [Full Text] [Related]
12. Application of molecular biology studies to gene therapy treatment strategies.
Gustin A; Pederson L; Miller R; Chan C; Vickers SM
World J Surg; 2002 Jul; 26(7):854-60. PubMed ID: 11960211
[TBL] [Abstract][Full Text] [Related]
13. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy.
Fleming JB; Shen GL; Holloway SE; Davis M; Brekken RA
Mol Cancer Res; 2005 Jul; 3(7):413-23. PubMed ID: 16046552
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer inhibition by specific knockdown of K-ras mutant allele expression.
Bernhard EJ
Cancer Biol Ther; 2007 Feb; 6(2):293-4. PubMed ID: 17387263
[No Abstract] [Full Text] [Related]
15. [Detection of the Ki-ras mutation as a specific and sensitive marker of pancreatic carcinoma].
Krechler T; Janda J; Dufek V; Kaláb M; Pesková M; Dorazilová V
Vnitr Lek; 1997 Oct; 43(10):678-81. PubMed ID: 9601883
[TBL] [Abstract][Full Text] [Related]
16. Re: Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.
Melzer E
Gastrointest Endosc; 2012 Sep; 76(3):702-3; author reply 703. PubMed ID: 22898430
[No Abstract] [Full Text] [Related]
17. Targeting microRNAs in pancreatic cancer: microplayers in the big game.
Khan S; Ansarullah ; Kumar D; Jaggi M; Chauhan SC
Cancer Res; 2013 Nov; 73(22):6541-7. PubMed ID: 24204026
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for pancreatic cancer.
Tseng JF; Mulligan RC
Surg Oncol Clin N Am; 2002 Jul; 11(3):537-69. PubMed ID: 12487056
[TBL] [Abstract][Full Text] [Related]
19. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
Tada M; Omata M; Ohto M
Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
